BIOMAT Database Logo BIOMAT Database Logo

Development of quinolone-resistant Campylobacter fetus bacteremia in human immunodeficiency virus-infected patients. 1998

P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
Department of Infectious Diseases, Wilford Hall Medical Center, Ft. Sam Houston, TX, USA.

Campylobacter fetus subspecies fetus has been recognized as a cause of systemic illness in immunocompromised hosts, including relapsing bacteremia in human immunodeficiency virus (HIV)-infected patients. Acquired resistance to quinolone therapy, while reported for a variety of bacteria, including Campylobacter jejuni, has not been previously documented for C. fetus. Two cases of quinolone-resistant C. fetus bacteremia were detected in HIV-infected patients. Cloning and nucleotide sequencing of the C. fetus gyrA gene in the 2 resistant isolates demonstrated a G-to-T change that led to an Asp-to-Tyr amino acid substitution at a critical residue frequently associated with quinolone resistance. In addition, comparison of the pre- and posttreatment isolates from 1 patient documented outer membrane protein changes temporally linked with the development of resistance. Relapsing C. fetus infections in quinolone-treated HIV-infected patients may be associated with the acquisition of resistance to these agents, and this resistance may be multifactorial.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002168 Campylobacter fetus A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion. Spirillum fetus,Vibrio fetus
D002169 Campylobacter Infections Infections with bacteria of the genus CAMPYLOBACTER. Campylobacter Infection,Campylobacteriosis,Infections, Campylobacter,Campylobacterioses,Infection, Campylobacter
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
Bacteremia due to Campylobacter cinaedi in a patient infected with the human immunodeficiency virus.
July 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
[Campylobacter fetus subsp fetus bacteremia in a female patient infected by the hepatitis C virus].
January 2004, Annales de biologie clinique,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
Mycobacterium kansasii bacteremia in patients infected with human immunodeficiency virus.
October 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review.
January 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients.
October 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
[Infected abdominal aortic aneurysm from Campylobacter fetus bacteremia].
July 2008, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
[Campylobacter fetus bacteremia].
April 1983, Harefuah,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
[Campylobacter fetus bacteremia].
February 1983, Schweizerische medizinische Wochenschrift,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
Campylobacter fetus subspecies fetus bacteremia.
February 1985, Archives of internal medicine,
P A Meier, and D P Dooley, and J H Jorgensen, and C C Sanders, and W M Huang, and J E Patterson
Group C streptococcal bacteremia in patients infected with the human immunodeficiency virus.
April 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!